6Peyvandi F,Palla R, Lotta LA, et al.ADAMTS-13 assays in thrombotic thrombocytopenic purpura.J Thromb Haemost ,2010,8 : 631-640.
7Yang S, Jin M, Lin S, et al. ADAMTS13 activity and antigell during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura:correlation with clinincal out come.Haematologica, 2011 , 96 : 1521-1527.
8Mannucci PM,Canciani MT,Forza I, et al. Changes in health and disease of the metalloprotease that cleaves yon Willebrand factor. Blood, 2001, 98:2730-2735.
9Galbusera M, Noris M,Rossi C, et al. Increased fragmentation of yon Willebrand factor,due to abnormal cleavage of the subunit,parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families.The Italian Registry of Familial and Recurrent HUS/TTP.Blood,1999.94 : 610-620.
10Fontana S,Hovinga JA,Studt JD,et al.Plasma therapy in thrombotic thrombocytopenic purpura :review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 defocoemcy.Semin Hematol, 2004, 41:48-59.
